The relationship between acute ischaemic stroke and plasma D-dimer levels in patients developing neither venous thromboembolism nor major intercurrent illness
- PMID: 14517488
- DOI: 10.1097/00001721-200310000-00004
The relationship between acute ischaemic stroke and plasma D-dimer levels in patients developing neither venous thromboembolism nor major intercurrent illness
Abstract
The true relationship between plasma D-dimers and acute ischaemic stroke (AIS) is uncertain as previous studies investigating this have not screened for subclinical deep vein thrombosis. We addressed this as part of a study in which we screened AIS patients for venous thromboembolism (VTE). We also assessed the performance characteristics of two D-dimer assays as exclusionary tests for VTE in these patients. One hundred and two unselected AIS patients were screened for VTE using magnetic resonance direct thrombus imaging. D-dimers were analysed on days 2, 9, 14 and 21 using the VIDAS immunofluorescent assay (cut-off >or= 500 ng/ml) and the IL test D-dimer immunoturbidimetric assay (cut-off >or= 255 ng/ml). The relationship between D-dimers and AIS was examined in 52 patients neither developing VTE nor intercurrent illness. D-dimers were elevated throughout the study. Median values at the four time points were 652, 692, 737 and 686 ng/ml (VIDAS assay) and 260.5, 268.5, 273 and 283 ng/ml (IL assay). D-dimers were higher in patients aged older than 70 years, with severe stroke or with total anterior circulation infarcts: only age older than 70 years was significantly associated with D-dimer values greater than the median on univariate and multivariable analysis. Both assays were 100% sensitive for VTE. Specificities were 30% (VIDAS assay) and 34% (IL assay). Specificity was adversely affected by age older than 70 and severe versus non-severe stroke. D-dimers are elevated in the first 3 weeks post-AIS after eliminating the confounding effect of subclinical deep vein thrombosis. The VIDAS and IL assays remained sensitive tests for VTE but the specificity was low, limiting their exclusionary efficiency in these patients.
Similar articles
-
Extensive evaluation of the instrumentation laboratory IL test D-Dimer immunoturbidimetric assay on the ACL 9000 determines the D-Dimer cutoff value for reliable exclusion of venous thromboembolism.Lab Hematol. 2004;10(2):88-94. doi: 10.1532/LH96.04018. Lab Hematol. 2004. PMID: 15224764
-
Screening for proximal deep vein thrombosis after acute ischemic stroke: a prospective study using clinical factors and plasma D-dimers.J Thromb Haemost. 2004 Aug;2(8):1321-6. doi: 10.1111/j.1538-7836.2004.00843.x. J Thromb Haemost. 2004. PMID: 15704260
-
Rapid detection of D-Dimers with mLabs® whole blood method for venous thromboembolism exclusion. Comparison with Vidas® D-Dimers assay.Int Angiol. 2016 Dec;35(6):622-628. Epub 2015 Nov 17. Int Angiol. 2016. PMID: 26576665
-
D-dimer testing in the diagnosis of acute venous thromboembolism.Thromb Haemost. 1999 Aug;82(2):688-94. Thromb Haemost. 1999. PMID: 10605769 Review.
-
Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools.Semin Vasc Med. 2005 Nov;5(4):351-64. doi: 10.1055/s-2005-922480. Semin Vasc Med. 2005. PMID: 16302156 Review.
Cited by
-
D-dimers increase in acute ischemic stroke patients with the large artery occlusion, but do not depend on the time of artery recanalization.J Thromb Thrombolysis. 2010 May;29(4):477-82. doi: 10.1007/s11239-009-0372-9. J Thromb Thrombolysis. 2010. PMID: 19568692 Clinical Trial.
-
Association of Level and Increase in D-Dimer With All-Cause Death and Poor Functional Outcome After Ischemic Stroke or Transient Ischemic Attack.J Am Heart Assoc. 2021 Feb 2;10(3):e018600. doi: 10.1161/JAHA.120.018600. Epub 2021 Jan 8. J Am Heart Assoc. 2021. PMID: 33412918 Free PMC article.
-
Association between higher systemic immune inflammation index (SII) and deep vein thrombosis (DVT) in patients with aneurysmal subarachnoid hemorrhage (aSAH) after endovascular treatment.Neurosurg Rev. 2023 Jun 20;46(1):142. doi: 10.1007/s10143-023-02048-7. Neurosurg Rev. 2023. PMID: 37338601
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical